Role of kinesin family member 14 in disease monitoring and prognosis in patients with gastrointestinal cancer

Chen,Ping; Fan,Weining; Hou,Yujin; Wang,Fang; Luo,Na

doi:10.3892/ol.2022.13276

Role of kinesin family member 14 in disease monitoring and prognosis in patients with gastrointestinal cancer

Authors:
- Ping Chen
- Weining Fan
- Yujin Hou
- Fang Wang
- Na Luo
View Affiliations

Affiliations: Department of Oncology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region 750004, P.R. China
Published online on: March 16, 2022 https://doi.org/10.3892/ol.2022.13276
Article Number: 156
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Kinesin family member 14 (KIF14) is not only involved in numerous essential biological activities, such as cytokinesis and myelination, but also regulates several malignant behaviors and progression of cancer. However, its role in gastrointestinal cancer is rarely reported. Therefore, the present study aimed to investigate the association of KIF14 expression with disease‑free survival (DFS) and overall survival (OS) times in patients with gastrointestinal cancer. A total of 101 patients with gastrointestinal cancer (36 patients with gastric cancer and 65 patients with colorectal cancer) were retrospectively reviewed, and their cancer samples were collected to detect the protein and mRNA expression levels of KIF14 using immunohistochemistry and reverse transcription‑quantitative PCR, respectively. KIF14 protein expression was increased in cancer tissues compared with adjacent tissues (all P<0.001). The protein expression levels of KIF14 were positively associated with T stage (P<0.001), distant metastases (P=0.007) and TNM stage (P<0.001), while KIF14 mRNA expression was positively associated with T stage (P<0.001), lymph node metastasis (P=0.004), distant metastases (P=0.001) and TNM stage (P<0.001). High protein and mRNA expression levels of KIF14 were associated with worse DFS (P<0.001) and OS (P=0.016) times. In addition, high KIF14 protein expression independently predicted unfavorable DFS times (P=0.007). Subgroup analysis revealed that in patients with gastric cancer, KIF14 expression was associated with DFS and OS times, while in patients with colorectal cancer, KIF14 expression was only associated with DFS time, but not with OS time. In conclusion, KIF14 expression was not only associated with advanced pathological differentiation and TNM stage but was also associated with poor survival time in patients with gastrointestinal cancer. These results indicate the potential of KIF14 as a biomarker for gastrointestinal cancer prognosis.

View Figures

View References

1	Smyth EC, Nilsson M, Grabsch HI, van Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648. 2020. View Article : Google Scholar : PubMed/NCBI
2	Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I and Bray F: Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; Lyon: 2020, https://gco.iarc.fr/todayDecember 1–2018
3	Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, Ho J and Unverzagt S: Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 8:CD0040642017.PubMed/NCBI
4	Patel TH and Cecchini M: Targeted therapies in advanced gastric cancer. Curr Treat Options Oncol. 21:702020. View Article : Google Scholar : PubMed/NCBI
5	Bonelli P, Borrelli A, Tuccillo FM, Silvestro L, Palaia R and Buonaguro FM: Precision medicine in gastric cancer. World J Gastrointest Oncol. 11:804–829. 2019. View Article : Google Scholar : PubMed/NCBI
6	Lyons K, Le LC, Pham YT, Borron C, Park JY, Tran CTD, Tran TV, Tran HT, Vu KT, Do CD, et al: Gastric cancer: Epidemiology, biology, and prevention: A mini review. Eur J Cancer Prev. 28:397–412. 2019. View Article : Google Scholar : PubMed/NCBI
7	Zahir Ahmed S, Cirocchi N, Saxton E and Brown MK: Incidence of age migration of colorectal cancer in younger population: Retrospective single centred-population based cohort study. Ann Med Surg (Lond). 74:1032142021. View Article : Google Scholar : PubMed/NCBI
8	Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics, 2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
9	Carleton M, Mao M, Biery M, Warrener P, Kim S, Buser C, Marshall CG, Fernandes C, Annis J and Linsley PS: RNA interference-mediated silencing of mitotic kinesin KIF14 disrupts cell cycle progression and induces cytokinesis failure. Mol Cell Biol. 26:3853–3863. 2006. View Article : Google Scholar : PubMed/NCBI
10	Gruneberg U, Neef R, Li X, Chan EH, Chalamalasetty RB, Nigg EA and Barr FA: KIF14 and citron kinase act together to promote efficient cytokinesis. J Cell Biol. 172:363–372. 2006. View Article : Google Scholar : PubMed/NCBI
11	Cullati SN, Kabeche L, Kettenbach AN and Gerber SA: A bifurcated signaling cascade of NIMA-related kinases controls distinct kinesins in anaphase. J Cell Biol. 216:2339–2354. 2017. View Article : Google Scholar : PubMed/NCBI
12	Ahmed SM, Thériault BL, Uppalapati M, Chiu CW, Gallie BL, Sidhu SS and Angers S: KIF14 negatively regulates Rap1a-Radil signaling during breast cancer progression. J Cell Biol. 199:951–967. 2012. View Article : Google Scholar : PubMed/NCBI
13	Wang W, Shi Y, Li J, Cui W and Yang B: Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancer. Biosci Rep. 36:e003152016. View Article : Google Scholar : PubMed/NCBI
14	Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS and Gallie BL: KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clin Cancer Res. 13:3229–3234. 2007. View Article : Google Scholar : PubMed/NCBI
15	Zhang Y, Yuan Y, Liang P, Zhang Z, Guo X, Xia L, Zhao Y, Shu XS, Sun S, Ying Y and Cheng Y: Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer. Oncotarget. 8:45459–45469. 2017. View Article : Google Scholar : PubMed/NCBI
16	Yang Z, Li C, Yan C, Li J, Yan M, Liu B, Zhu Z, Wu Y and Gu Q: KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer. Biochim Biophys Acta Mol Basis Dis. 1865:181–192. 2019. View Article : Google Scholar : PubMed/NCBI
17	Klimaszewska-Wiśniewska A, Neska-Długosz I, Buchholz K, Durślewicz J, Grzanka D, Kasperska A, Antosik P, Zabrzyński J, Grzanka A and Gagat M: Prognostic significance of KIF11 and KIF14 expression in pancreatic adenocarcinoma. Cancers (Basel). 13:30172021. View Article : Google Scholar : PubMed/NCBI
18	Li X, Huang W, Huang W, Wei T, Zhu W, Chen G and Zhang J: Kinesin family members KIF2C/4A/10/11/14/18B/20A/23 predict poor prognosis and promote cell proliferation in hepatocellular carcinoma. Am J Transl Res. 12:1614–1639. 2020.PubMed/NCBI
19	Edge SB and Compton CC: The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
20	Niederle MB, Hackl M, Kaserer K and Niederle B: Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European neuroendocrine tumour society classification: An analysis based on prospectively collected parameters. Endocr Relat Cancer. 17:909–918. 2010. View Article : Google Scholar : PubMed/NCBI
21	Zhang T, Shi W, Tian K and Kong Y: Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma. World J Surg Oncol. 18:1562020. View Article : Google Scholar : PubMed/NCBI
22	Fu H, Jin C, Zhu Q, Liu T, Ke B, Li A and Zhang T: Dysregulated expressions of PTEN, NF-κB, WWP2, p53 and c-Myc in different subtypes of B cell lymphoma and reactive follicular hyperplasia. Am J Transl Res. 11:1092–1101. 2019.PubMed/NCBI
23	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
24	Neska-Długosz I, Buchholz K, Durślewicz J, Gagat M, Grzanka D, Tojek K and Klimaszewska-Wiśniewska A: Prognostic impact and functional annotations of KIF11 and KIF14 expression in patients with colorectal cancer. Int J Mol Sci. 22:97322021. View Article : Google Scholar : PubMed/NCBI
25	Xiao L and Zhang S, Zheng Q and Zhang S: Dysregulation of KIF14 regulates the cell cycle and predicts poor prognosis in cervical cancer: A study based on integrated approaches. Braz J Med Biol Res. 54:e113632021. View Article : Google Scholar : PubMed/NCBI
26	Li KK, Qi Y, Xia T, Chan AK, Zhang ZY, Aibaidula A, Zhang R, Zhou L, Yao Y and Ng HK: The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis. Lab Invest. 97:946–961. 2017. View Article : Google Scholar : PubMed/NCBI
27	Zhu Q, Ren H, Li X, Qian B, Fan S, Hu F, Xu L and Zhai B: Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma. Aging (Albany NY). 12:22975–23003. 2020.PubMed/NCBI
28	Thériault BL, Cybulska P, Shaw PA, Gallie BL and Bernardini MQ: The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells. J Ovarian Res. 7:1232014. View Article : Google Scholar : PubMed/NCBI
29	Thériault BL, Pajovic S, Bernardini MQ, Shaw PA and Gallie BL: Kinesin family member 14: An independent prognostic marker and potential therapeutic target for ovarian cancer. Int J Cancer. 130:1844–1854. 2012. View Article : Google Scholar : PubMed/NCBI
30	Wang ZZ, Yang J, Jiang BH, Di JB, Gao P, Peng L and Su XQ: KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer. Int J Oncol. 53:1939–1952. 2018.PubMed/NCBI
31	Han BA, Yang XP, Hosseini DK, Zhang P, Zhang Y, Yu JT, Chen S, Zhang F, Zhou T and Sun HY: Identification of candidate aberrantly methylated and differentially expressed genes in esophageal squamous cell carcinoma. Sci Rep. 10:97352020. View Article : Google Scholar : PubMed/NCBI
32	Chen J, Ma C, Zhang Y, Pei S, Du M, Zhang Y, Qian L, Wang J, Yin L and He X: MiR-154-5p suppresses cell invasion and migration through inhibiting KIF14 in nasopharyngeal carcinoma. Onco Targets Ther. 13:2235–2246. 2020. View Article : Google Scholar : PubMed/NCBI